Document is current
Any future updates will be listed below
-
Authors
Høj, Stine Bordier
Coignard-Friedman, Rémi
Sako, Aissata
de Montigny, Catherine
Beauchemin-Nadeau, Marie-Ève
Léandre, Robert
Minoyan, Nanor
Boyer-Legault, Geneviève
Chougar, Sofiane
Lamont, Sara-Kim
Bruneau, Julie
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (REN-181678; CUG-171602; 950-232703, REN-181678; CUG-171602; 950-232703, REN-181678; CUG-171602; 950-232703, REN-181678; CUG-171602; 950-232703)
- License Information
-
More Information
Article History
Received: 18 April 2025
Accepted: 4 October 2025
First Online: 10 November 2025
Declarations
:
: The study was approved by the Centre Hospitalier de l’Université de Montréal (CHUM) research ethics board. All participants signed an informed consent to participate in the study. The analysis plan was not pre-registered and results should be considered exploratory.
: Not applicable.
: JB reports a relationship with Gilead Sciences that includes: consulting or advisory and funding grants and a relationship with AbbVie that includes: consulting or advisory, outside the scope of this manuscript. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
